Table 2 Clinicopathological features of HPV-16-positive lung carcinomas
From: Human papillomavirus-16 presence and physical status in lung carcinomas from Asia
| Â | Â | All N(%) | HPV16 positive N(%) | HPV16 negative N(%) | p-value |
|---|---|---|---|---|---|
Age | Â | Â | Â | Â | 0.669 |
| Â | < 65 years | 38 | 4 (11) | 34 (89) | Â |
| Â | > 65 years | 18 | 3 (17) | 15 (83) | Â |
Gender | Â | Â | Â | Â | 0.091 |
| Â | Male | 43 | 8 (19) | 35 (81) | Â |
| Â | Female | 17 | 0 (0) | 17 (100) | Â |
Histology | Â | Â | Â | Â | < 0.001 |
| Â | AC | 38 | 0 (0) | 38 (100) | Â |
| Â | SQC | 18 | 8 (44) | 10 (56) | Â |
| Â | SCLC | 4 | 0 (0) | 4 (100) | Â |
Differentiation | Â | Â | Â | Â | 0.131 |
| Â | Poor | 19 | 5 (26) | 14 (74) | Â |
| Â | Moderate | 26 | 3 (12) | 23 (88) | Â |
| Â | Well | 11 | 0 (0) | 11 (100) | Â |
Country | Â | Â | Â | Â | 0.001 |
| Â | Pakistan | 21 | 7 (33) | 14 (67) | Â |
| Â | China | 31 | 0 (0) | 31 (100) | Â |
| Â | PNG | 8 | 1 (13) | 9 (87) | Â |